Turnstone Biologics Q1 EPS $(0.85) Misses $(0.78) Estimate
Portfolio Pulse from Benzinga Newsdesk
Turnstone Biologics (NASDAQ:TSBX) reported a Q1 EPS loss of $(0.85), missing the consensus estimate of $(0.78) by 8.97%.
May 13, 2024 | 9:05 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Turnstone Biologics reported a larger than expected quarterly loss, missing analyst estimates.
Earnings misses typically lead to negative investor sentiment in the short term, potentially causing a decrease in stock price as expectations are adjusted.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100